? Post-market safety surveillance of medical devices is a complex task compounded by rapid dissemination of new medical technology, lack of standards in data collection, and inadequate passive adverse event reporting mechanisms. Building an effective surveillance system is challenging because data are generally not available in an acceptable timeframe and there is lack of consensus regarding the most appropriate methodologies to be used to identify low frequency safety threats. We have developed a computerized tool, DELTA (Data Extraction and Longitudinal Time Analysis system), that can monitor the adverse event rates of new medical devices through the continuous surveillance of clinical outcomes databases using a variety of statistical monitoring tools. We tested and validated DELTA on a large clinical database at a single center within the domain of interventional cardiology and showed that the system was efficient in identifying very low frequency events. In addition we have explored various alerting algorithms triggered by event trends. ? We propose to extend the DELTA surveillance system to monitor a Massachusetts state-wide mandated outcomes data registry in interventional cardiology that is rigorously collected according to national standards. The DELTA system will be modified to support continuous monitoring utilizing dichotomous and continuous outcome analytic methods. In addition, the system will be validated against historical registry data as well as randomized trial data in which there were significant safety issues identified. Also, we propose to implement DELTA as a secure distributed network of analytic engines at four participating centers in MA. We will """"""""de-identify"""""""" patient information using algorithms that quantify the degree of """"""""anonymity"""""""" of the disclosed data. This system will be evaluated and compared with traditional methods for adverse event detection by assessing the safety of several classes of new devices, including new drug eluting coronary stents, embolic protection devices, and vascular closure devices in over 40,000 patients. The sensitivity, specificity, time savings and cost effectiveness of the DELTA network will be prospectively evaluated. ? The DELTA network may offer a valuable complementary approach to existing methods for medical device safety surveillance. This approach can be readily extended to monitor the safety of technologies outside of interventional cardiology as outcomes data repositories become available. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Library of Medicine (NLM)
Type
Research Project (R01)
Project #
5R01LM008142-06
Application #
7495681
Study Section
Biomedical Library and Informatics Review Committee (BLR)
Program Officer
Sim, Hua-Chuan
Project Start
2003-09-30
Project End
2010-09-29
Budget Start
2008-09-30
Budget End
2009-09-29
Support Year
6
Fiscal Year
2008
Total Cost
$427,870
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Govindarajulu, Usha; Bedi, Sandeep; Kluger, Aaron et al. (2018) Survival analysis of hierarchical learning curves in assessment of cardiac device and procedural safety. Stat Med 37:4185-4199
Kumar, Amit; Matheny, Michael E; Ho, Kalon K L et al. (2015) The data extraction and longitudinal trend analysis network study of distributed automated postmarket cardiovascular device safety surveillance. Circ Cardiovasc Qual Outcomes 8:38-46
Vidi, Venkatesan D; Matheny, Michael E; Govindarajulu, Usha S et al. (2012) Vascular closure device failure in contemporary practice. JACC Cardiovasc Interv 5:837-44
Resnic, Frederic S; Wang, Tracy Y; Arora, Nipun et al. (2012) Quantifying the learning curve in the use of a novel vascular closure device: an analysis of the NCDR (National Cardiovascular Data Registry) CathPCI registry. JACC Cardiovasc Interv 5:82-9
Matheny, Michael E; Normand, Sharon-Lise T; Gross, Thomas P et al. (2011) Evaluation of an automated safety surveillance system using risk adjusted sequential probability ratio testing. BMC Med Inform Decis Mak 11:75
Resnic, Frederic S; Normand, Sharon-Lise T; Piemonte, Thomas C et al. (2011) Improvement in mortality risk prediction after percutaneous coronary intervention through the addition of a ""compassionate use"" variable to the National Cardiovascular Data Registry CathPCI dataset: a study from the Massachusetts Angioplasty Registry. J Am Coll Cardiol 57:904-11
Dauerman, Harold L; Rao, Sunil V; Resnic, Frederic S et al. (2011) Bleeding avoidance strategies. Consensus and controversy. J Am Coll Cardiol 58:1-10
Vidi, Venkatesan D; Matheny, Michael E; Donnelly, Sharon et al. (2011) An evaluation of a distributed medical device safety surveillance system: the DELTA network study. Contemp Clin Trials 32:309-17
Bangalore, Sripal; Vidi, Venkatesan D; Liu, Christopher B et al. (2011) Efficacy and safety of the nitinol clip-based vascular closure device (Starclose) for closure of common femoral arterial cannulation at or near the bifurcation: a propensity score-adjusted analysis. J Invasive Cardiol 23:194-9
Resnic, Frederic S; Gross, Thomas P; Marinac-Dabic, Danica et al. (2010) Automated surveillance to detect postprocedure safety signals of approved cardiovascular devices. JAMA 304:2019-27

Showing the most recent 10 out of 26 publications